Literature DB >> 32963961

Sars-CoV-2 isolation from a 10-day-old newborn in Italy: A case report.

Giuseppe Lenoci1, Domenico Galante2, Edmondo Ceci1, Viviana Manzulli2, Angela Maria Moramarco1, Anna Chiaromonte1, Giuseppina Labarile1, Simone Lattarulo1, Annalisa Resta1, Lorenzo Pace2, Valeria Rondinone2, Antonio Parisi2, Dora Cipolletta2, Leonardo Marino2, Iolanda Padalino2, Luigina Serrecchia2, Angela Aceti2, Michela Iatarola2, Francesco Tolve2, Antonio Fasanella2.   

Abstract

This report describes the evolution of COVID-19 in a 10 day-old-baby. The mother developed the disease immediately after childbirth and therefore a vertical transmission can be excluded. The isolation of the virus in cell culture with a cytopathic effect already visible after 48 h, indicates that the viral load of the newborn was quite high, but not serious course of the disease was observed. This paper wants to highlight the possible role of newborns and children in the spread of the disease.
© 2020 The Authors. Published by Elsevier Ltd.

Entities:  

Keywords:  COVID-19; Cell-culture; Isolation; Newborn; Sars-CoV-2

Year:  2020        PMID: 32963961      PMCID: PMC7497735          DOI: 10.1016/j.idcr.2020.e00960

Source DB:  PubMed          Journal:  IDCases        ISSN: 2214-2509


Introduction

It is not yet clear why children, and especially newborns, are less susceptible to COVID-19 than adults [1], despite viral infections being much more frequent from childhood onwards. One hypothesis is related to vaccinations that are carried out in the first weeks of life and which would favor an increase of a non-specific immunity related to an increase in inteleukin-2 (IL-2) or other factors not yet known [2]. Probably some interactions between the newborn and the most common respiratory viruses of childhood would stimulate an innate resistance to RNA viruses [3]. Another hypothesis concerns angiotensin-converting enzyme 2 (ACE2), a membrane-bound aminopeptidase which is highly expressed in pulmonary alveolar epithelial cells and small intestine enterocytes. Although ACE2 has been identified as a receptor for Sars-CoV-2, it is plausible that ACE2 tissue distribution differs between adults and children or that ACE2 binding capacity in children is lower than in adults [4]. One reason why infant do not develop severe forms of the disease could be due to the fact that the immune system of infants is not mature at all and therefore probably is not yet able to start the cytokine storm that occurs in COVID-19 infection of the adults [5]. In fact, from a clinical point of view, COVID-19 generally occurs in children with moderate or low fever accompanied by mild and non-specific symptoms. In some cases, gastrointestinal symptoms such as diarrhea, abdominal distension and aversion to food may occur in newborns [6]. Hypoxia and increased respiratory rate were recorded only in a small subgroup of children, which in severe cases does not respond to standard oxygen therapy and requires nasal cannula or mask. Based on the reported cases, most of these children have a benign course which resolves within 1–2 weeks after the onset of the disease. Infants with COVID-19 need more careful and cautious observation because they are more likely to present with non-specific symptoms such as lethargy and dehydration [4,7,8].

Case report

On 09 August 2020, a 34-year-old pregnant woman was admitted to the "Mater Dei" hospital (Bari, Apulia region, Italy) and following the standard procedures before the entrance was subjected to the nasopharyngeal swab for Sars-CoV-2 detection, resulting negative despite manifesting cold symptoms, but without fever. Also an internal reaction control was used in order to exclude a false negativity. On the same day the woman gave birth to a child weighing 3.100 Kg. Three days later mother and son came back home and after 10 days from the birth, the newborn developed low-grade fever and mild respiratory symptoms. For this reason he was transferred to the pediatric hospital “Giovanni XXIII” (Bari, Apulia region, Italy), but he couldn’t be hospitalized because he was less than 30 days old. On 20 August 2020 he was transferred to the neonatology department of “Miulli” hospital (Acquaviva delle Fonti, Apulia region, Italy) for suspected sepsis since he manifested fever with a temperature of 37.8 °C. Immediately he was subjected to the following tests: complete blood count, C reactive protein, film array for the detection of Adenovirus, Coronavirus 229E-HKQ1-NL63-OC43, Metapneumovirus human, Rhinovirus, Enterovirus, Influenza A-B, Parainfluenza 1-2-3-4, RSV, Pertussis, Chlamydia and Mycoplasma pneumonia. No lombar puncture was performed at the beginning, because the newborn showed mild respiratory symptoms and therefore a respiratory infection was suspected at first instance. The values of the complete blood count were normal e C reactive protein resulted negative. Moreover, was not revealed the presence of respiratory pathogens. Finally, it was decided to perform also the canonical nasopharyngeal swab to verify an eventual Sars-CoV-2 infection. The real time PCR specific for Sars-CoV-2 was performed by Allplex 2019-nCoV Assay Kit (Seegene, Seul, Korea) on the CFX96 Real Time System C1000 Thermal Cycler (Bio-Rad, Hercules, California-USA). The test resulted positive showing the amplification of the E gene with CT 9.7; RdRp gene with CT 13.3; and N gene with CT 14.5. After the results, the newborn was transferred to the infectious disease department of the pediatric hospital “Giovanni XXIII” (Bari). The day after, on 21 August, all his four family members (mother, father and two young brothers) were also tested for Sars-CoV-2, because the father complained of headache and sore throat and one of the children had 375 °C fever. Mother, father and the older brother resulted positive to the test, while the youngest one resulted negative, probable because in those days he had not been in strict contact with his family, but he was living temporarily with his maternal grandparents. It’s important to underline that the paternal grandmother during the days following the birth of the child complained a strong headache and cold flu symptoms and she went to visit the family at their home. The old woman was subjected to Sars-CoV-2 swab in the same day of the other relatives and she resulted to be positive. Probably she was the person who infected the others. Since that time all the family members were subjected to mandatory quarantine under the direct responsibility of the local health authorities. The nasopharyngeal swab of the newborn was sent to the BSL-3 laboratory of the Istituto Zooprofilattico Sperimentale della Puglia e della Basilicata (Foggia, Apulia region, Italy) for the isolation test. Briefly, 500 μL of the swab medium was incubated with 250 μL of an antibiotic solution for 1 h at room temperature. The suspension was then inoculated in a T25 Cell Culture Flask containing a monolayer of VeroE6 cells. The flask was incubated in a thermostat at 37 °C for 1 h. After incubation, 5.5 mL of EMEM with 6 % fetal bovine serum were added and incubated again at 37 °C. After 48 h of incubation a quite good cytopathic effect was appreciable. After further 24 h, an impressive cytopathic effect was highlighted consisting of rounding and detachment of most of the cells (Fig. 1). The replication of the virus was confirmed by the specific biomolecular test for Sars-CoV-2 carried out on 200 μL of the culture medium.
Fig. 1

Cytopathic effects consisting of rounding and detachment of cells in Vero E 6 cell cultures, 72 h after the inoculation of the virus from the swab medium.

Cytopathic effects consisting of rounding and detachment of cells in Vero E 6 cell cultures, 72 h after the inoculation of the virus from the swab medium. The newborn manifested fever for 3 days following the admission and then the heath conditions resulted stable.

Discussion

The newborn almost certainly contracted Sars-CoV-2 from one member of the family, presumably the paternal grandmother who, most likely, was infective in the days following the birth, when she went to visit the newborn at his home. We do not know if the newborn or another family member infected the others, but it’s very interesting that the viral load of the newborn was very high as demonstrated either by PCR or by isolation of the virus. The cytopathic effect on the Vero E6 monolayer was already evident after 48 h post inoculation and was much clearer after 72 h (Fig. 1). Despite the high viral load, the newborn never showed serious symptoms except mild respiratory symptoms and a not high fever for 3 days following the admission to the pediatric hospital. This case confirms what has already been reported in other similar works, even in presence of high viral loads, newborns usually show relatively mild symptoms [9]. This case requires a reflection on the potentiality of Sars-CoV-2 transmission from newborns and children that, maybe, often is underestimated. Moreover, some traditional behaviors of the Italian population and in particular of Southern Italy, where it is customary to visit newborn children in the days immediately following the return home, can amplify the transmission of Sars-CoV-2 from unknown infected children. In fact, newborns living inside home environment can spreadlarge quantities of virus and lead to high levels of contamination, so as to be dangerous for anyone who comes into contact with them. It’s unlikely that that infant would generate effective cough aerosols for infection, but however they can have infectious secretions such as stool or saliva as reported in literature [10,11]. Therefore, the aim of this paper is to report that also from Sars-CoV-2 positive newborns is possible to isolate alive virus even in presence of moderate symptoms, as showed by the isolation on cell culture of this study, indicating that they could be dangerous for the dissemination of the virus.

Ethical considerations

Written informed consent was obtained from the patient for the publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request. All authors have made substantial contributions to thefollowing: (1) the conception and design of the study, oracquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectualcontent, (3) final approval of the version to be submitted.

CRediT authorship contribution statement

Giuseppe Lenoci: Conceptualization, Project administration, Supervision, Visualization, Writing - original draft. Domenico Galante: Conceptualization, Supervision, Visualization, Writing - original draft. Edmondo Ceci: Conceptualization, Supervision, Visualization, Writing - original draft. Viviana Manzulli: Data curation, Formal analysis, Investigation. Angela Maria Moramarco: Investigation, Formal analysis, Investigation, Methodology, Software, Validation. Anna Chiaromonte: Formal analysis, Investigation, Methodology, Software, Validation. Giuseppina Labarile: Formal analysis, Investigation, Methodology, Software, Validation. Simone Lattarulo: Formal analysis, Investigation, Methodology, Software, Validation. Annalisa Resta: Formal analysis, Investigation, Methodology, Software, Validation. Lorenzo Pace: Data curation, Formal analysis, Investigation, Methodology. Valeria Rondinone: Data curation, Formal analysis, Investigation, Methodology. Antonio Parisi: Conceptualization, Formal analysis, Investigation, Methodology, Visualization. Dora Cipolletta: Data curation, Formal analysis, Investigation, Methodology. Leonardo Marino: Formal analysis, Investigation, Methodology. Iolanda Padalino: Formal analysis, Investigation, Methodology. Luigina Serrecchia: Formal analysis, Investigation, Methodology. Angela Aceti: Formal analysis, Formal analysis, Investigation, Methodology. Michela Iatarola: Formal analysis, Investigation, Methodology. Francesco Tolve: Formal analysis, Investigation, Methodology. Antonio Fasanella: Project administration, Supervision, Visualization, Writing - original draft.

Declaration of Competing Interest

The authors report no declaration of interests.
  8 in total

1.  Detection of SARS-CoV-2 in Different Types of Clinical Specimens.

Authors:  Wenling Wang; Yanli Xu; Ruqin Gao; Roujian Lu; Kai Han; Guizhen Wu; Wenjie Tan
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

2.  2019-nCoV: Polite with children!

Authors:  Désirée Caselli; Maurizio Aricò
Journal:  Pediatr Rep       Date:  2020-02-11

Review 3.  Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus.

Authors:  Zhi-Min Chen; Jun-Fen Fu; Qiang Shu; Ying-Hu Chen; Chun-Zhen Hua; Fu-Bang Li; Ru Lin; Lan-Fang Tang; Tian-Lin Wang; Wei Wang; Ying-Shuo Wang; Wei-Ze Xu; Zi-Hao Yang; Sheng Ye; Tian-Ming Yuan; Chen-Mei Zhang; Yuan-Yuan Zhang
Journal:  World J Pediatr       Date:  2020-02-05       Impact factor: 2.764

4.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

5.  SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics.

Authors:  Qing Cao; Yi-Ching Chen; Chyi-Liang Chen; Cheng-Hsun Chiu
Journal:  J Formos Med Assoc       Date:  2020-03-02       Impact factor: 3.282

Review 6.  Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far.

Authors:  Domenico Umberto De Rose; Fiammetta Piersigilli; Maria Paola Ronchetti; Alessandra Santisi; Iliana Bersani; Andrea Dotta; Olivier Danhaive; Cinzia Auriti
Journal:  Ital J Pediatr       Date:  2020-04-29       Impact factor: 2.638

Review 7.  Innate Immune Evasion by Human Respiratory RNA Viruses.

Authors:  Marjolein Kikkert
Journal:  J Innate Immun       Date:  2019-10-14       Impact factor: 7.349

8.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

  8 in total
  1 in total

1.  Fatal relapse of COVID-19 after recovery? A case report of an older Italian patient.

Authors:  Francesco Bellanti; Aurelio Lo Buglio; Giacomo Custodero; Lucia Barbera; Graziano Minafra; Marcella Montrano; Fabio De Biase; Gianluigi Vendemiale
Journal:  J Infect       Date:  2020-12-16       Impact factor: 6.072

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.